Open Access
CeO2 -Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals
Sofia Khabirova
1
,
Gleb Aleshin
1
,
Tatiana Plakhova
1
,
Anastasia Zubenko
2
,
Anna Shchukina
2
,
Olga Fedorova
2
,
Aleksey Averin
3
,
Ekaterina Belova
1
,
Elena Bazarkina
4, 5
,
Kristina Kvashnina
4, 5
,
4
Publication type: Journal Article
Publication date: 2022-12-18
PubMed ID:
36558337
General Chemical Engineering
General Materials Science
Abstract
This study is one of the first attempts to assess CeO2 nanoparticles as a nanoplatform for radiopharmaceuticals with radionuclides. The process of functionalization using a bifunctional azacrown ligand is described, and the resulting conjugates are characterized by IR and Raman spectroscopy. Their complexes with 207Bi show a high stability in medically relevant media, thus encouraging the further study of these conjugates in vivo as potential combined radiopharmaceuticals.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
Inorganic Chemistry
2 publications, 18.18%
|
|
|
Materials
1 publication, 9.09%
|
|
|
Dalton Transactions
1 publication, 9.09%
|
|
|
Cells
1 publication, 9.09%
|
|
|
Tetrahedron
1 publication, 9.09%
|
|
|
Journal of Structural Chemistry
1 publication, 9.09%
|
|
|
Chemistry - A European Journal
1 publication, 9.09%
|
|
|
RSC Medicinal Chemistry
1 publication, 9.09%
|
|
|
Microchemical Journal
1 publication, 9.09%
|
|
|
ACS Omega
1 publication, 9.09%
|
|
|
1
2
|
Publishers
|
1
2
3
|
|
|
American Chemical Society (ACS)
3 publications, 27.27%
|
|
|
MDPI
2 publications, 18.18%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 18.18%
|
|
|
Elsevier
2 publications, 18.18%
|
|
|
Pleiades Publishing
1 publication, 9.09%
|
|
|
Wiley
1 publication, 9.09%
|
|
|
1
2
3
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
11
Total citations:
11
Citations from 2024:
7
(63%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Khabirova S. et al. CeO2-Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals // Nanomaterials. 2022. Vol. 12. No. 24. p. 4484.
GOST all authors (up to 50)
Copy
Khabirova S., Aleshin G., Plakhova T., Zubenko A., Shchukina A., Fedorova O., Averin A., Belova E., Bazarkina E., Kvashnina K., Kalmykov S. CeO2-Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals // Nanomaterials. 2022. Vol. 12. No. 24. p. 4484.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3390/nano12244484
UR - https://www.mdpi.com/2079-4991/12/24/4484
TI - CeO2-Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals
T2 - Nanomaterials
AU - Khabirova, Sofia
AU - Aleshin, Gleb
AU - Plakhova, Tatiana
AU - Zubenko, Anastasia
AU - Shchukina, Anna
AU - Fedorova, Olga
AU - Averin, Aleksey
AU - Belova, Ekaterina
AU - Bazarkina, Elena
AU - Kvashnina, Kristina
AU - Kalmykov, Stepan
PY - 2022
DA - 2022/12/18
PB - MDPI
SP - 4484
IS - 24
VL - 12
PMID - 36558337
SN - 2079-4991
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Khabirova,
author = {Sofia Khabirova and Gleb Aleshin and Tatiana Plakhova and Anastasia Zubenko and Anna Shchukina and Olga Fedorova and Aleksey Averin and Ekaterina Belova and Elena Bazarkina and Kristina Kvashnina and Stepan Kalmykov},
title = {CeO2-Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals},
journal = {Nanomaterials},
year = {2022},
volume = {12},
publisher = {MDPI},
month = {dec},
url = {https://www.mdpi.com/2079-4991/12/24/4484},
number = {24},
pages = {4484},
doi = {10.3390/nano12244484}
}
Cite this
MLA
Copy
Khabirova, Sofia, et al. “CeO2-Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals.” Nanomaterials, vol. 12, no. 24, Dec. 2022, p. 4484. https://www.mdpi.com/2079-4991/12/24/4484.